Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 82 entries
View as:

Completely Abdominal Approach Laparoscopic Partial Intersphincteric Resection for Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04481659 Org: User:
Start: 07/19/20 End: 07/19/25 Due: 07/19/26

The Effect of Eyeliner on Tear Composition, Tear Secretion and Tear Film Stability.

Phase: N/A Priority: Normal
NCT ID: NCT05632887 Org: User:
Start: 02/15/23 End: 04/15/23 Due: 04/15/24

A Clinical Trial on Booster Immunization of Two COVID-19 Vaccines Constructed From Different Technical Routes

Phase: N/A Priority: Normal
NCT ID: NCT05886790 Org: User:
Start: 05/30/23 End: 05/29/24 Due: 05/29/25

Aberrant Myeloid Lineage Differentiation in HIV/AIDS Patients

Phase: N/A Priority: Normal
NCT ID: NCT05808803 Org: User:
Start: 01/01/16 End: 01/31/22 Due: 01/31/23

Noninvasive and Dynamic Monitoring the Biological Parameters of Eyes in Different Age Groups

Phase: N/A Priority: Normal
NCT ID: NCT05250440 Org: User:
Start: 02/01/22 End: 12/31/24 Due: 12/31/25

Retrospective Analysis of the Clinical Characteristics of Retinal Vein Occlusion

Phase: N/A Priority: Normal
NCT ID: NCT06757595 Org: User:
Start: 01/01/18 End: 12/25/24 Due: 12/25/25

Safety and Efficacy of Esmketamine Versus Dexmedetomidine

Phase: N/A Priority: Normal
NCT ID: NCT04877639 Org: User:
Start: 05/01/21 End: 05/01/23 Due: 05/01/24

A Cross-sectional Study of Ocular Manifestations During the Covid-19 Pandemic in Hubei Province

Phase: N/A Priority: Normal
NCT ID: NCT06355128 Org: User:
Start: 01/01/24 End: 04/30/24 Due: 04/30/25

The Value of Peripheral Blood CD34+ Cell Dynamics Monitoring in Autologous Hematopoietic Stem Cell Transplant Mobilization

Phase: N/A Priority: Normal
NCT ID: NCT05970185 Org: User:
Start: 02/01/24 End: 04/30/24 Due: 04/30/25

Adjuvant IMRT With Concommitant Raltitrexed Chemotherapy for Locally Advanced Gastric Cancer After D0/D1 Radical Resection

Phase: N/A Priority: Normal
NCT ID: NCT03392103 Org: User:
Start: 01/31/17 End: 12/31/19 Due: 12/31/20

Circulating Tumor Cell Capture for Early Diagnosis and Postoperative Tumor Recurrence Monitoring of Liver Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04688606 Org: User:
Start: 01/22/20 End: 05/20/21 Due: 05/20/22

Effect of Es-ketamine on Postoperative Delirium Among Old Patients With Lobectomy

Phase: N/A Priority: Normal
NCT ID: NCT04969523 Org: User:
Start: 07/31/21 End: 12/31/22 Due: 12/31/23

Docetaxel Alone or in Combination With Enzalutamide for mCRPC Previously Treated With Abiraterone at mHSPC Stage

Phase: N/A Priority: Normal
NCT ID: NCT05627752 Org: User:
Start: 06/01/24 End: 12/31/25 Due: 12/31/26

Disitamab Vedotin Combined With Fruquintinib for mCRC With HER2 Expression

Phase: N/A Priority: Normal
NCT ID: NCT05661357 Org: User:
Start: 01/01/23 End: 12/31/25 Due: 12/31/26

Plasma-free Replacement in Patients With Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT05251896 Org: User:
Start: 01/01/20 End: 01/31/23 Due: 01/31/24

Surufatinib Alone or Combined With Anti-PD-1 mAb in the Treatment of Advanced Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT05282433 Org: User:
Start: 04/16/22 End: 12/31/24 Due: 12/31/25

Infusion Set Replacement Intervals for Critically Ill Patients

Phase: N/A Priority: Normal
NCT ID: NCT05359601 Org: User:
Start: 05/15/22 End: 06/30/26 Due: 06/30/27

Effects of Metabolic Enzymes and Transporter Gene Polymorphisms on the Pharmacokinetics and Metabolism of Oral Abiraterone Acetate in Healthy Chinese Adults

Phase: N/A Priority: Normal
NCT ID: NCT04735913 Org: User:
Start: 05/05/20 End: 07/01/22 Due: 07/01/23

Bortezomib Combined With DAG Regimen in the Treatment of Refractory/Relapsed AML

Phase: N/A Priority: Normal
NCT ID: NCT05982756 Org: User:
Start: 01/01/20 End: 12/01/23 Due: 12/01/24

Granzyme B-targeted PET Imaging Monitoring Tumor Responses to Immunotherapy

Phase: N/A Priority: Normal
NCT ID: NCT06916442 Org: User:
Start: 04/01/25 End: 12/31/27 Due: 12/31/28

Autoimmunity Contributes to the Severe Progression of COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT04967781 Org: User:
Start: 03/10/20 End: 05/27/21 Due: 05/27/22

Fibroblast Activation Protein Inhibitor PET/CT Imaging in Malignant Tumor of Digestive System

Phase: N/A Priority: Normal
NCT ID: NCT05420558 Org: User:
Start: 06/23/22 End: 12/31/23 Due: 12/31/24

Research on the Accurate Diagnosis of Urinary Tract Tumors and the Development of Kits

Phase: N/A Priority: Normal
NCT ID: NCT06193941 Org: User:
Start: 06/01/23 End: 12/01/23 Due: 12/01/24

Efficacy of Semi-rigid Ureteroscopic Laser Lithotripsy in the Treatment of Proximal Ureteral Stones: a Randomized Controlled Trial

Phase: N/A Priority: Normal
NCT ID: NCT06489366 Org: User:
Start: 06/26/24 End: 02/26/25 Due: 02/26/26

Multiple Biomarkers in ICU Sepsis Patients

Phase: N/A Priority: Normal
NCT ID: NCT03802136 Org: User:
Start: 12/30/18 End: 06/30/19 Due: 06/30/20